Cabot Investors Conference in Salem, MA


The first-ever Cabot Investors Conference is set for August 14-15 at the Hawthorne Hotel in Salem, Massachusetts.

At the Conference, attendees will interact with like-minded investors from all over the U.S. and Canada in a comfortable atmosphere with the unique ability to really get to know the Cabot advisors. Presenters include all the Cabot experts: Tim Lutts, Mike Cintolo, Paul Goodwin, Tom Garrity, Roy Ward, Jacob Mintz, Chloe Lutts Jensen and Robin Carpenter. Topics include growth stocks, value stocks, ETFs, options, investing systems, stock chart analysis and more.

According to Chief Investment Strategist Tim Lutts, “The goal of the Conference is to help attendees apply the Cabot investment processes to boost their own returns. We expect each participant will leave the Conference with the latest actionable and timely investment recommendations.”

To date, subscribers from 29 states and two Canadian provinces are already registered. Cabot subscribers who are planning on attending the Conference but haven’t reserved their spots yet are urged to register now.

For more information, visit the Cabot Investors Conference website, which has all the details on the agenda and activities, and the registration form, or call Cabot Customer Service at 978-745-5532

Stock Picks


This stock could rise 50% before becoming fairly valued.

This hot technology company is growing like a weed, thanks to products that speed up cloud communications.

This stock is somewhat well known, but far from well loved.

Cabot Wealth Advisory

How to Find Great Growth Stocks in a Scary Market

By Paul Goodwin on October 21, 2016

Even in today’s scary market, there are great growth stocks out there. Here’s how to find them—and how to avoid the kind of losses that can haunt your portfolio.Read More >

Buy This Small-Cap Tech Stock as the Nasdaq Thrives

By Tyler Laundon on October 20, 2016

Technology stocks are thriving, as the Nasdaq has been outpacing the S&P 500 and the Dow for months. And one small-cap tech stock in particular is outperforming the industry’s big boys. Read More >

Is Allergan (AGN) Still an Undervalued Stock?

By Crista Huff on October 18, 2016

Five months ago, Allergan (AGN) was an undervalued stock with tons of growth potential. It's up 21% since then, but still has plenty of upside. Here's why.Read More >